netFormulary

Lancashire and South Cumbria
Formulary

13 Skin

Dermatology prescribing may require use of expensive unlicensed
creams and ointments (known as ‘Specials’). Please consult the revised British Association of Dermatologists (BAD) list of preferred Specials (2018) for advice on appropriate product choice.

Several medicines in the skin chapter are available for purchase over the counter and may be appropriate for self care. Please consult the local OTC policy for more details.

LSCMMG: Over The Counter (OTC) Items That Should Not Be Routinely Prescribed In Primary Care Policy

13-06 Acne and rosacea

Brimonidine tartrate Mirvaso^®

Formulary

Gel 3mg/g

Restricted to use in patients with moderate to severe, persistent facial erythema of rosacea.

LSCMMG: Brimonidine Tartrate (Mirvaso) 3mg/g Gel NMR

MHRA: Brimonidine gel (Mirvaso): risk of exacerbation of rosacea

MHRA: Brimonidine gel (Mirvaso): risk of systemic cardiovascular effects; not to be applied to damaged skin

Ivermectin

Formulary

Cream 10mg/g

Topical treatment of inflammatory lesions of rosacea (papulopustular) in adults.

Appropriate for initiation and on-going prescribing in both primary and secondary care. To be used as an alternative treatment when metronidazole and azelaic acid topical preparations are not effective, contraindicated or not tolerated by the patient. Ivermectin cream may be tried for a 3 month period, at which point it can be stopped if not effective or continued if effective.

For indications relating to oral ivermectin see subsection 05.05 Anthelmintics.

LSCMMG: Ivermectin cream 10mg/g (Soolantra�) NMR

Links